<SEC-DOCUMENT>0001628280-22-021048.txt : 20220804
<SEC-HEADER>0001628280-22-021048.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220804160337
ACCESSION NUMBER:		0001628280-22-021048
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220804
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		221136413

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgmo-20220804.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ade49f8c-698c-4f5b-833c-4195b1e9f742,g:18ee06a9-130d-42df-8877-192c3b8d83a6,d:d06fc469778d4396b28592d55c6c733b--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20220804</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1f3b08a735f0431a8acb4f701aeefaf6_D20220804-20220804" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQwNmZjNDY5Nzc4ZDQzOTZiMjg1OTJkNTVjNmM3MzNiL3NlYzpkMDZmYzQ2OTc3OGQ0Mzk2YjI4NTkyZDU1YzZjNzMzYl80L2ZyYWc6ZmE0NjUxNzUxZjU1NDA5N2JlOGRmN2RkZmEwNjFmZGQvdGFibGU6NjBiYjhiMTE2YTY2NDBlM2E1MWZiOGQyY2VmMDY3YmYvdGFibGVyYW5nZTo2MGJiOGIxMTZhNjY0MGUzYTUxZmI4ZDJjZWYwNjdiZl8yLTEtMS0xLTQ5MDIy_cf7d5472-269b-4633-b80a-a6c00516e17d">August 4, 2022</ix:nonNumeric><ix:nonNumeric contextRef="i1f3b08a735f0431a8acb4f701aeefaf6_D20220804-20220804" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQwNmZjNDY5Nzc4ZDQzOTZiMjg1OTJkNTVjNmM3MzNiL3NlYzpkMDZmYzQ2OTc3OGQ0Mzk2YjI4NTkyZDU1YzZjNzMzYl80L2ZyYWc6ZmE0NjUxNzUxZjU1NDA5N2JlOGRmN2RkZmEwNjFmZGQvdGFibGU6NjBiYjhiMTE2YTY2NDBlM2E1MWZiOGQyY2VmMDY3